Trial Details
COMPLETEDBasic Information
| Clinical ID | c1153 |
|---|---|
| Identifier | NCT01694485 |
| Trial Title | Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: Abrilumab|DRUG: Placebo |
Participant Information
| Sponsor | Amgen |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2012-11-16 |
|---|---|
| Primary Completion Date | 2015-07-13 |
| Completion Date | 2018-04-10 |